The Weekly Scale: July 5th, 2021

This week at MarketScale, we held a major press conference on the future of retail and delivery, hosted a true legend of education, and examined what “retailtainment” will look like in 2022. That’s making my wallet cringe.

Break out the ice chests for the dog days of summer— it’s time to scale up.

What’s being done to reimagine the next decade of education?

To find answers, our very own JW Marshall sat down with EdTech legend Sal Khan of the one and only Khan Academy. Make sure you don’t miss this incredible interview, which also featured AT&T’s Mylayna Albright, as the trio dove into silver linings for education after a year of disruption and more.

Space to Grow just wrapped up its first season, so Chris Blackerby and Charity Weeden looked back on past conversations regarding space sustainability, policy, technology and more. They also took a moment to look ahead, sharing what they hope to bring to the show in its second season.

Conflict archaeology is a new subfield in the world of anthropology.

This week on Discover the Truth by Garrett Metal Detectors, I talked with retired soldier Danny Keay about how this field doesn’t just focus on battle sites. For instance, construction sites, factory sites, prisoner of war camps, areas where soldiers rested or camped out, and more – it’s all on deck for these discoverers and preservers of history.

Get ready to roll the dice and play the slots, because live events are back in Las Vegas.

This week on SandenVendo’s Unwrapped podcast, they previewed the Nightclub and Bar show, one of the biggest of the year — and perhaps the clearest sign yet that the world is getting back to face-to-face interaction. What do they expect from this year’s event? Tune in to find out.

I’ll be back next Monday for The Weekly Scale but, until then, if you know of a story that you want us to cover, let us know with the hashtag B2BNeverSleeps.

Follow us on social media for the latest updates in B2B!

Image

Latest

cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More
organoids
Growing the Future of Cancer Research: Inside the Promise of Organoids
April 19, 2025

In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…

Read More
Immuno-Oncology
Shaping the Future of Cancer Care Through Immuno-Oncology
April 19, 2025

In the ever-evolving world of cancer treatment, immuno-oncology (IO) continues to stand at the forefront of innovation. With recent FDA approvals for TIL therapies and bispecific antibodies, and new developments in CAR-T technologies, the field is rapidly expanding into combination-based strategies that integrate with standard care. Researchers are also exploring how to overcome challenges posed…

Read More